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402a Tuesday, February 5, 2013positive allosteric modulators by interacting with the Ca2þ binding site. In ad-
dition, extracellular Ca2þ differentially reduces the inhibition of the receptor by
antagonists and negative allosteric modulators. Our studies open a new avenue
for modulating drug effects and developing novel drugs against neurodegener-
ative diseases.
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Experimental investigations of ligand-activated receptors are often based on
binding measurements that detect the total fraction of occupied binding sites
at various ligand concentrations. We use calmodulin, an important calcium sen-
sor protein, as a test system to document the uncertainties in model parameters
estimated by fitting various models to total binding data. Using nonlinear
least-squaresmethods, we obtain excellent fits (<1%RMSerror) to synthetic to-
tal binding data with the same characteristics as the published binding data using
parameter sets with binding affinities varying by over four orders of magnitude
for each site. This result identifies a significant obstacle blocking progress to-
ward the goal of developing accurate, quantitativemodels of receptor activation.
The use of noiseless data in our analysis suggests that the large uncertainties in
the estimated parameters are not a problem of data quality, but rather reflect an
intrinsic limitation of total binding data. Using analytical matrix algebra tech-
niques and numerical simulations, we discover a fundamental relationship be-
tween the mathematical structure of the equations describing various types of
binding data and the number and type of parameters that may be determined
accurately from regression analysis of that data. Ideas based on Boolean logical
principles are used to design a new type of binding experiment that significantly
improves upon total binding data in its power to constrain physically realistic
models of receptor activation. These experiments, which we call conditional
binding, report on the simultaneous occupancies of two different receptor bind-
ing sites. Our approach is general and the conclusions are applicable to the many
macromolecular systems that are activated or modulated by ligand binding.
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Fructuose bisphostate aldolase (FBA) and triosephosphate isomerase (TIM) are
the fourth and fifth enzymes in the glycolysis pathway and they are known to
bind. FBA cleaves the six-carbon fructose 1, 6-bisphosphate into two three-
carbon components – dihydroxyacetone phosphate (DHAP) and glyceralde-
hyde 3-phosphate (GAP). TIM converts DHAP into GAP, a substrate for the
subsequent synthetic step. These two alpha/beta barrel proteins have high struc-
tural similarity – with a core RMSD 4.8A˚. These two enzymes have low activ-
ity in the monomeric form with the functionally active structures present in
higher oligomeric states. By applying Elastic Network Model, we find the
modes of motions that are functionally important for these proteins. We build
models for the complex between these two proteins to investigate their impor-
tant motions in their complexes as well as for their different oligomeric states
including those that are different in different species to learn their important
modes of motions for different functionalities. For each protein, by multiple se-
quence alignment across the species, we predict the coevolving residues and
cluster these residues along the structure. We build the information transfer
pathways from the important interface residues to the catalytic residues.
Change in these pathways in different oligomeric states maybe be related to
the change of motions in the catalytic region in different oligomeric states.
We use this knowledge about the changes in motions and the information trans-
fer pathways within the structure of these interacting proteins as constraints for
selecting the computational docked models of complexes between these two
proteins to preserve their functional motions.
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For several transcription factors, the same ligand can act as a positive and neg-
ative allosteric effector in a context dependent manner. The structural and
molecular bases of such effects are unknown. Here it is shown that modulation
of conformational fluctuations within allosteric systems can be used as a mech-anism to tune protein ensembles such that a given ligand can act as both a pos-
itive and negative allosteric effector. Importantly, this mechanism can be
robustly encoded in the ensemble, and does not require that the interactions be-
tween the ligand and the protein differ when it is acting either as a positive or
negative effector. Instead, the effect is due to the relative probabilities of states
prior to the addition of the ligand and is encoded in the thermodynamic cou-
pling architectures between protein domains. The ensemble view of allostery
that is illuminated by these studies suggests that rather than being seen as
switches with fixed responses to allosteric activation, ensembles can evolve
to be ‘‘functionally pluripotent’’, with the capacity to up or down regulate ac-
tivity in response to a stimulus. This result not only helps to explain the prev-
alence of intrinsic disorder in transcription factors and other cell signaling
proteins, it provides important insights about the energetic ground rules govern-
ing site-to-site communication in all allosteric systems.
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Kinases are one of the most intensively pursued drug targets investigated for
the treatment of cancer. Kinase inhibitors usually target the ATP binding
site; however, the similarity of this site across many kinases often results to
non-selectivity. Therefore, allosteric modulation of kinases is of paramount im-
portance as it may result in increased selectivity; many highly selective inhib-
itors have been reported to inhibit kinases by allosteric mechanisms. PI3Ka is
the most frequently mutated kinase in human cancers with one of its most com-
mon mutations being a histidine changed to arginine in exon 20 (H1047R).
PIK-108, a known PI3Ka inhibitor, was recently found to occupy an allosteric
binding pocket in the wild type (WT) murine protein, close to the H1047R mu-
tation. In order to assess the interactions, stability and allosteric effects of the
inhibitor on PI3Ka, MD simulations in aqueous solution were performed for
130ns for the WT human, WT murine, and H1047R human mutant proteins
with PIK-108 placed in both catalytic and allosteric sites. Interestingly, PIK-
108 remained stable in both sites in all three variants. While in both the WT
human and murine forms, the same ligand:protein interaction motifs are ob-
served in the allosteric and catalytic pockets, these interactions are markedly
different in the mutant form. In the mutant form, the allosteric pocket opens
up and forms an altered hydrogen bond network with the ligand compared to
theWT. Additionally, in the catalytic pocket, significant differences are evident
in the interaction network formed between the inhibitor, P-loop, and the activa-
tion loop between the two protein forms. Overall, the ligand:protein interaction
differences between the mutant andWT PI3Ka proteins observed in the present
study provide a rich basis for the design of mutant-specific PI3Ka inhibitors.
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Calcium sensing receptor (CaSR), along other members of the family C G
protein-coupled receptors (GPCRs), play very important roles in responding
to changes in the extracellular calcium concentrations and in circulating levels
of amino acids and integrating these extracellular signals into alterations in in-
tracellular signaling pathways. However, detailed structure properties of the
CaSR which are necessary to characterize the mechanism of its physiological
function are still unrevealed. We have reported several potential calcium-
binding sites located within the CaSR’s extracellular domain using our
developed computational algorithms. In the present study, we first report the
differential effects of several disease-related mutations located at the predicted
calcium binding sites on the inhibition and activation of intracellular calcium
responses using single cell imaging. Mutating to different residues at two lo-
cations near the hinge region of the ECD could lead to either significantly
lose of function of the receptor or gain of function (switch function mutations).
Amino acid binding results in differential rescue effect in altering intracellular
calcium responses, especially calcium oscillations.We have further probe the
effect of mutation and amino acid binding on the correlation motion, cooper-
ativity, and synergistic activation using mammalian expressed and purified
